Recruiting
Phase 1
Phase 2

Cord Blood Derived Mesenchymal Stem Cells

Sponsor:

M.D. Anderson Cancer Center

Code:

NCT04565665

Conditions

COVID-19 Infection

COVID-19-Associated Acute Respiratory Distress Syndrome

Hematopoietic and Lymphoid Cell Neoplasm

Malignant Solid Neoplasm

Symptomatic COVID-19 Infection Laboratory-Confirmed

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Best Practice

Mesenchymal Stem Cell

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-01. This information was provided to ClinicalTrials.gov by M.D. Anderson Cancer Center on 2025-03-20.